# $lfmd Telehealth stocks like $LFMD are being overlooked despite strong partnerships and industry growth, while competitors like $NVO see massive demand for their products. Investors are questioning the market's logic as some stocks soar while others lag. ### About $lfmd $LFMD is a digital platform focused on user interaction and content sharing, particularly within the healthcare and telehealth sector. ### Top $lfmd Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "Probably no read through from RO commentary for $LFMD. $NVO Demand for the (wegovy) pill is beyond what anyone expected. We expected it to be tremendous and it's an order of magnitude more than that. And it's really been incredible. This is RO ceo @ZReitano talking about the launch of wegovy pill. RO have likely the biggest Demand for the (wegovy) pill is beyond what anyone expected. We expected it to be tremendous and it's an order of magnitude more than that. And it's really been incredible. This is RO ceo @ZReitano talking about the launch of wegovy pill. RO have likely the biggest" [X Link](https://x.com/ValueNotDeadYet/status/2017237016912552402) [@ValueNotDeadYet](/creator/x/ValueNotDeadYet) 2026-01-30T14:02Z [----] followers, [----] engagements "Wegovy sales are crushing it and $NVO is (rightfully) up big since launch. Meanwhile telehealth companies that also sell Wegovylike $LFMD or $WWare way down. Make it make sense. Its not that market picked a winner; theres blood across the board" [X Link](https://x.com/harisvromas/status/2017218926749344011) [@harisvromas](/creator/x/harisvromas) 2026-01-30T12:50Z [---] followers, [---] engagements "Think you cant go wrong taking a spec position in any of these Telehealth names $GDRX $LFMD $WW in front of $NVO print as well as each of their own. All so beaten up and priced for doom and signs of strength in subscriber growth driven by oral GLP should pop these names well IMO" [X Link](https://x.com/CapitalVennett/status/2016967335723049253) [@CapitalVennett](/creator/x/CapitalVennett) 2026-01-29T20:11Z [---] followers, [---] engagements "$LFMD Market rotation is a real thing. I do not want to buy markets at all time highs. That being said you have a company that is: .67 P/S 87% GM has a deal with $LLY (NVDA of healthcare) & $NVO (AMD of health care) [--] Debt 46m cash on a 160m mkt cap Growing 20%+ In an industry doing 22% CAGR I may come off as a trader to many of you but the goal is always to accumulate more of the things I believe in. At times that means buying something else when the risk/reward is better in another stock. I have made $LFMD 70% of my portfolio as I have it 190% from fair value. It is in LEAPS [--] years out" [X Link](https://x.com/TeleHInvesting/status/2014411351725334883) [@TeleHInvesting](/creator/x/TeleHInvesting) 2026-01-22T18:54Z [---] followers, [----] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Telehealth stocks like $LFMD are being overlooked despite strong partnerships and industry growth, while competitors like $NVO see massive demand for their products. Investors are questioning the market's logic as some stocks soar while others lag.
$LFMD is a digital platform focused on user interaction and content sharing, particularly within the healthcare and telehealth sector.
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Probably no read through from RO commentary for $LFMD. $NVO Demand for the (wegovy) pill is beyond what anyone expected. We expected it to be tremendous and it's an order of magnitude more than that. And it's really been incredible. This is RO ceo @ZReitano talking about the launch of wegovy pill. RO have likely the biggest Demand for the (wegovy) pill is beyond what anyone expected. We expected it to be tremendous and it's an order of magnitude more than that. And it's really been incredible. This is RO ceo @ZReitano talking about the launch of wegovy pill. RO have likely the biggest"
X Link @ValueNotDeadYet 2026-01-30T14:02Z [----] followers, [----] engagements
"Wegovy sales are crushing it and $NVO is (rightfully) up big since launch. Meanwhile telehealth companies that also sell Wegovylike $LFMD or $WWare way down. Make it make sense. Its not that market picked a winner; theres blood across the board"
X Link @harisvromas 2026-01-30T12:50Z [---] followers, [---] engagements
"Think you cant go wrong taking a spec position in any of these Telehealth names $GDRX $LFMD $WW in front of $NVO print as well as each of their own. All so beaten up and priced for doom and signs of strength in subscriber growth driven by oral GLP should pop these names well IMO"
X Link @CapitalVennett 2026-01-29T20:11Z [---] followers, [---] engagements
"$LFMD Market rotation is a real thing. I do not want to buy markets at all time highs. That being said you have a company that is: .67 P/S 87% GM has a deal with $LLY (NVDA of healthcare) & $NVO (AMD of health care) [--] Debt 46m cash on a 160m mkt cap Growing 20%+ In an industry doing 22% CAGR I may come off as a trader to many of you but the goal is always to accumulate more of the things I believe in. At times that means buying something else when the risk/reward is better in another stock. I have made $LFMD 70% of my portfolio as I have it 190% from fair value. It is in LEAPS [--] years out"
X Link @TeleHInvesting 2026-01-22T18:54Z [---] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$lfmd